Weight loss is frequently recommended for people who are newly diagnosed with type 2 diabetes, but weight loss after new-onset diabetes may increase risk for pancreatic cancer, researchers say. The researchers suggest screening for pancreatic cancer in patients with diabetes and weight loss. Read more
A recent study assessed loneliness by asking more than 4,000 adults without type 2 diabetes how often they felt isolated or lacking companionship. Participants were followed up for about 10 years to see how many developed diabetes. By the end of the study, loneliness was associated with 46 percent greater odds of developing type 2 […]
People with type 2 diabetes are known to have problems with cardiovascular exercises; their reduced peak of VO2 (the maximum rate of oxygen consumption measured during incremental exercise) is linked to the development of cardiovascular diseases. A recent study sought a better understanding of the link between cardiovascular dysfunction and type 2 diabetes. Read more
Researchers have found that going to bed early may be beneficial for people with type 2 diabetes. People with type 2 who were night owls, staying up late and rising later in the morning, were less likely to get adequate exercise than those who maintained earlier bedtimes, researchers say. Read more
Researchers are finding a two-way relationship between COVID-19 and diabetes: people with diabetes are at increased risk of severe complications from COVID-19, and people who contract COVID-19 are at an increased risk of new-onset diabetes. An international research project, the CoviDIAB Registry project, will seek to understand why. Read more
For most people diagnosed with type 2 diabetes, the first treatments to be prescribed (aside from lifestyle changes like diet and exercise) are metformin or sulfonylureas. If these do not achieve the desired result, doctors may add additional medications. New research says that there is reason to add the SGLT-2 inhibitor early, as the second […]
People whose mothers had diabetes during pregnancy are at increased risk for early heart disease as young adults. The researchers say that the risk applies to both children of mothers who have pre-existing type 2 diabetes when they become pregnant, and children whose mothers developed gestational diabetes during their pregnancies. Read more
Diabetes-related cardiovascular diseases can be prevented by relatively simple and affordable steps, researchers say, including improved communication between healthcare providers and patients, improved early detection, and better control of factors like blood glucose, cholesterol, and blood pressure. Read more
Proton pump inhibitors, or PPIs, are a class of drugs used to treat acid reflux, peptic ulcers and indigestion. Researchers have found regular use of these drugs is linked to an increased risk of developing type 2 diabetes, and the risk increases the longer the drugs are taken. Read more
New research suggests that regular heat exposure through a hot bath is associated with a beneficial effect on risk factors for type 2 diabetes, including glycated haemoglobin |(HbA1c), which is a measure of blood sugar control. Read more
Research has shown that remission of type 2 diabetes, which can be achieved through intensive weight loss, can restore the insulin production capability of the pancreas. Now new research has found that remission can also restore the pancreas to its pre-diabetes shape and size. Read more
Eating whole grain foods can help prevent type 2 diabetes, researchers say. Even something as simple as having a bowl of whole-grain cereal or a piece of whole-grain toast for breakfast can reduce your long-term risk of developing type 2 diabetes. Read more
A new data modelling study says that the average person with type 1 diabetes in the UK today will live almost eight years less than an average person who does not have diabetes, while those with type 2 diabetes will live almost 2 years less than a person without type 2. Read more
It’s been recognized for some time that 2 diabetes is associated with an increased risk of dementia. A recent large study provides new insight into both the types of dementia implicated and some of the causative factors, finding that the risk is highest for vascular dementia, and the greatest risk is to individuals with poor […]
Recent diabetes guidelines have suggested giving type 2 diabetes patients newer glucose-lowering drugs like SGLT2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors, earlier in preference to older drugs like metformin and the sulfonylureas, due to their many benefits. However, for Medicare recipients, the out-of-pocket costs for these drugs are much higher. Read more
British researchers say that over the last two decades the number of people with prediabetes who subsequently develop type 2 diabetes has declined. While changes in prediabetes classifications may have contributed, earlier treatment of prediabetes by the National Health Service may also be making a difference. Read more
Drugs from the SGLT2 inhibitor class of diabetes medications have shown benefit in slowing progression of diabetic kidney disease, with a reduced risk of acute kidney injury (AKI) noted in research trials. People at high risk of AKIs who may be considering SGLT2 treatment should discuss the risks and benefits with their doctors. Read more
End-stage kidney disease (ESKD) is a serious complication experience by many people with type 2 diabetes, and sometimes necessitate a kidney transplant. Researchers say delaying or preventing the onset of type 2 diabetes in people who have prediabetes can make a dramatic difference in their odds of developing ESKD. Read more
The FDA has approved 2 additional doses of Eli Lilly’s Trulicity (dulaglutide) for treating type 2 diabetes. The approval of the new 3.0 mg and 4.5 mg doses of dulaglutide was based on clinical trial results showing benefits for A1C levels and weight loss. Read more
Researchers say they have identified insomnia as a risk factor for increased risk of developing type 2 diabetes (T2D). Their conclusion came as part of a study that identified 34 factors that could either increase or decrease the risk for type 2. Read more
